Skip to content
ApprovedFDA approvedStrong evidence

Nortriptyline

Secondary-amine tricyclic antidepressant (NET-preferring), Rx for depression and neuropathic pain.

AntidepressantTricyclic antidepressantAntidepressantMoodNorepinephrineSerotoninAcetylcholinenoo.affects.histamine
Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pharmacology

ClassAntidepressant · Mood
Primary targetNorepinephrine transporter (NET) reuptake inhibition
Targets5 receptor targets
Half-lifeAbout 18 to 44 hours (roughly one day)
OnsetMood benefit typically develops over 2 to 4 weeks; sleep and pain effects may appear sooner
EvidenceStrong evidence
Affected systemsNorepinephrineSerotoninAcetylcholinenoo.affects.histamine

Contents

WHAT IS NORTRIPTYLINE?

Detailed overview

Nortriptyline is a secondary-amine tricyclic antidepressant (TCA) and the active metabolite of amitriptyline, in clinical use since the 1960s. It works mainly by blocking the norepinephrine transporter (NET), with weaker serotonin reuptake inhibition, while also antagonizing histamine H1, muscarinic and alpha-1 adrenergic receptors, which drives most of its side effects. Beyond major depression it is widely used off-label for neuropathic pain, chronic tension-type headache and migraine prophylaxis, and as a second-line smoking-cessation aid. It has a comparatively narrow therapeutic window and a well-defined target plasma range (roughly 50 to 150 ng/mL), so it is a prescription drug that requires medical supervision and can be dangerous in overdose.

Mechanism

NET-preferring reuptake inhibitor (TCA)

Half-life

~18-44 hours (about a day)

Legal status

Prescription antidepressant (Rx)

Receptor profile

  • Norepinephrine transporter (NET)Strong
  • Serotonin transporter (SERT)Moderate
  • Histamine H1 receptorModerate
  • Muscarinic acetylcholine receptorModerate
  • Alpha-1 adrenergic receptorModerate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Anticholinergic effects: dry mouth, constipation, blurred vision, urinary retention
  • Drowsiness, sedation and weight gain (H1 antagonism)
  • Orthostatic hypotension and dizziness (alpha-1 blockade)
  • Cardiac effects: tachycardia, arrhythmia, QT changes; dangerous in overdose
  • Sexual dysfunction, sweating, tremor
  • Increased risk of suicidal ideation in people under 25 (class-wide warning)

Contraindications · 5

  • Recent myocardial infarction, significant heart disease or conduction defects
  • Concurrent or recent (within 14 days) MAO inhibitor use
  • Known hypersensitivity to tricyclic antidepressants
  • Caution or avoidance in mania and bipolar disorder (can trigger a switch), narrow-angle glaucoma, urinary retention and seizure disorders
  • Pregnancy and breastfeeding: only if clearly indicated, under medical advice

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Secondary-amine tricyclic antidepressant (NET-preferring), Rx for depression and neuropathic pain.

Telegram

Have a question about Nortriptyline?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeAntidepressant
FormulaC19H21N
UpdatedJuly 10, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: July 10, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.